Quest Diagnostics Incorporated: 10-K Risk Factor Changes

2025 vs 2024  ·  SEC EDGAR  ·  2026-10-16
Other years: 2026 vs 2025
⚠ AI Risk Brief Interpretation layer — deterministic data below

U.S. healthcare policy risk elevated with new regulatory language; modest modifications to product innovation and compliance governance.

Direction ↑ More concerning
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

1
New Risks
0
Removed
5
Modified
21
Unchanged
🟢 New in Current Filing Disclosure change9/10

Significant changes or developments in U.S. laws or policies, including changes in U.S. healthcare regulation, may have a material adverse effect on our business.

🟡 Modified Our approach to corporate responsibility may not satisfy all our stakeholders. 🔒
🟡 Modified Our business and operations could be adversely impacted by the FDA's approach to regulation. 🔒
🟡 Modified Failure to develop, acquire licenses for, introduce, or commercialize new tests, technology and services could negatively impact our testing volume, revenues and profitability. 🔒

And 2 more changes in the full comparison.

5 changes in this historical filing

The complete historical comparison (2025 vs 2024) is available on the Pro plan.

Get Pro access Already a Pro subscriber? View full diff →